zilganersen
ION373-CS1
Phase 3 small_molecule active
Quick answer
zilganersen for Alexander Disease is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Alexander Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active